JPRN-UMIN000032848
Completed
Phase 3
Study on indicators for predicting the therapeutic effect of SGLT2 inhibitors under actual clinical practice in T2DM patients - Study on indicators for predicting therapeutic effect of SGLT2 inhibitors.
Osaki Citizen Hospital0 sites100 target enrollmentJune 3, 2018
Conditionstype 2 diabetes mellituds
Overview
- Phase
- Phase 3
- Intervention
- Not specified
- Conditions
- type 2 diabetes mellituds
- Sponsor
- Osaki Citizen Hospital
- Enrollment
- 100
- Status
- Completed
- Last Updated
- 2 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- Not provided
Exclusion Criteria
- •1\) Anti\-glutamic acid decarboxylase (GAD) antibody above normal range. 2\) HBs antigen or/end HCV antibody is positive. 3\)Patients who discontinue the use of SGLT2 inhibitors during the period. 4\)Patients who were taking acarbose and/or herbal medicines.
Outcomes
Primary Outcomes
Not specified
Similar Trials
Recruiting
N/A
A study of factors which predicts the therapeutic effect of acotiamide on abdominal symptoms in patients with Functional dyspepsia.Functional dyspepsiaJPRN-UMIN000036265Akita University Graduate School of Medicine Department of Gastroenterology and Neurology200
Unknown
N/A
Investigation of method for prediction of therapeutic effect of adalimumab initial therapy for inflammatory bowel diseaselcerative colitis, Crohn's diseaseJPRN-UMIN000022727Ofuna Chuo Hospital20
Completed
N/A
Investigation of method for prediction of therapeutic effect of infliximab initial therapy for inflammatory bowel diseaselcerative colitis, Crohn's diseaseJPRN-UMIN000022726Ofuna Chuo Hospital20
Completed
N/A
Studies on the predictive factors of treatment outcome after intravitreal injection of Lucentis (ranibizumab) in eyes with macular edema associated with central retinal vein occlusion (CRVO)Central retinal vein occlusionJPRN-UMIN000012793Ophthalmology, Mie University Hospital30
Recruiting
N/A
Investigation of predictive factors for therapeutic efficacy of immunosuppressive therapy for inflammatory bowel disease using machine learningInflammatory bowel diseaseJPRN-UMIN000046284Kyorin University300